ArticleCancer immunology, immunotherapy : CII2023

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma.

Lavinia Patricia Mocan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.